BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 31

• 

  Earnings

  Gilead sets blockbuster bar for Yeztugo’s first full year on the market

  With initial patients coming back for their second dose of Gilead’s twice-yearly PrEP injection, the pharma thinks the shot will hit $1 billion in sales this year, serving as “a cornerstone in Gilead’s revenue growth story.”

  May 8, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Pipeline

  Ascendis retreats to rare endocrinology wheelhouse as cancer plans falter

  Before discontinuing the asset, Ascendis Pharma was studying onvapegleukin alfa in advanced or metastatic solid tumors, demonstrating a three- to four-month overall survival advantage over historical controls.

  May 8, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Manufacturing

  Lilly invests $4.5B in Indiana manufacturing, opens doors of 1st genetic medicine site

  Eli Lilly’s latest manufacturing expansion will support production of obesity blockbusters and next-gen assets, while the new Lilly Lebanon Advanced Therapies site will take experimental genetic medicines from research to commercialization.

  May 8, 2026

   · 

  1 min read

   · 

  Gabrielle Masson
• 

  Alzheimer’s disease

  Biogen, Eisai hit with 3-month delay for starting SubQ Alzheimer’s therapy

  The FDA’s extension will give reviewers more time to review a major amendment to Biogen and Eisai’s application for a subcutaneous induction formulation of Alzheimer’s therapy Leqembi. The new target action date is on Aug. 24.

  May 8, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  TRexBio to Present Late-Breaking Data at the Society for Investigative Dermatology (SID) Annual Meeting Supporting TNFR2 Agonism as a Therapeutic Strategy for Atopic Dermatitis

  May 8, 2026

   · 

  3 min read
• Press Releases

  BioRestorative Therapies Reports Expanded Phase 2 Blinded Dataset for BRTX-100 Showing Sustained Pain and Functional Improvements in Chronic Lumbar Disc Disease

  May 8, 2026

   · 

  8 min read
• Press Releases

  Glucotrack Announces IDE Submission for U.S. Clinical Study of its Novel Implantable Continuous Blood Glucose Monitoring Technology

  May 8, 2026

   · 

  4 min read
• Press Releases

  Ivy Parks of BD-Canada Appointed Chair of the Medtech Canada Board of Directors

  May 8, 2026

   · 

  3 min read
• Press Releases

  Medical Component Specialists Appoints Chris Hester as President and CEO to Drive Next Phase of Global Growth

  May 8, 2026

   · 

  2 min read
• Press Releases

  The Canadian Cancer Society welcomes Ontario’s move to lower colorectal cancer screening age to 45

  May 8, 2026

   · 

  2 min read